Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$62.17 - $97.62 $1.46 Million - $2.29 Million
23,475 Added 1.27%
1,869,493 $182 Million
Q4 2022

Feb 13, 2023

BUY
$60.21 - $77.74 $2.96 Million - $3.82 Million
49,099 Added 2.73%
1,846,018 $115 Million
Q3 2022

Nov 14, 2022

SELL
$72.92 - $99.73 $4.61 Million - $6.3 Million
-63,209 Reduced 3.4%
1,796,919 $131 Million
Q2 2022

Aug 12, 2022

BUY
$84.23 - $147.57 $1.01 Million - $1.76 Million
11,946 Added 0.65%
1,860,128 $176 Million
Q1 2022

May 12, 2022

BUY
$122.89 - $171.74 $2.41 Million - $3.36 Million
19,589 Added 1.07%
1,848,182 $256 Million
Q4 2021

Feb 10, 2022

BUY
$156.0 - $265.78 $1.65 Million - $2.81 Million
10,566 Added 0.58%
1,828,593 $334 Million
Q3 2021

Nov 09, 2021

BUY
$228.69 - $274.2 $12.2 Million - $14.6 Million
53,285 Added 3.02%
1,818,027 $470 Million
Q2 2021

Aug 11, 2021

BUY
$169.89 - $231.37 $300 Million - $408 Million
1,764,742 New
1,764,742 $405 Million

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.